Registry of multicenter endovascular treatment for superficial femoral artery and popliteal artery disease

Two-year results of endovascular treatment for femoropopliteal artery disease in Japan during the introduction of drug-eluting devices. Registry of multicenter endovascular treatment for superficial femoral artery and popliteal artery disease - GUIDE SFA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045937

Enrollment

1003

Registered

2021-10-30

Start date

2017-02-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral arterial disease: PAD

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria were as follows: (i) symptomatic patients with peripheral arterial disease and femoropopliteal lesions, (ii) patient availability for at least a 1-year follow-up after EVT, and (iii) Rutherford classification from grade 2 to grade 5.

Exclusion criteria

Exclusion criteria: Exclusion criteria were as follows: (1) scheduled major amputation, (2) acute limb ischemia, (3) difficulty in using contrast media and antiplatelet agents, (4) isolated P3 lesion, and (5) dementia

Design outcomes

Primary

Measure	Time frame
The efficacy endpoint was freedom from clinically-driven target lesion revascularization and improvement of maximum walking distance at 1-year and 2-year.	—

Countries

Japan

Contacts

Public ContactKenji Suzuki

Japan Endovascular Treatment Conference Program committee

k-y.suzuki@nifty.com092-834-2815

Outcome results